NCT05258279 2024-08-28Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR MutationsJuntendo UniversityPhase 2 Active not recruiting30 enrolled
NCT05318443 2023-12-27A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung CancerShanghai Institute Of Biological ProductsPhase 3 Completed512 enrolled